GO
Loading...

Martha Stewart Net Loss Widens, Company Boost Full-Year Guidance

CNBC.com
Thursday, 3 May 2007 | 8:28 AM ET

Martha Stewart Living Omnimedia said Thursday its first-quarter loss widened from the same quarter last year, with results dragged down by a charge related to syndicating the "Martha Stewart Show."

The media and merchandise company reported a loss of $11.9 million, or 23 cents a share, for the first quarter, which is greater than the loss of $6.84 million, or 13 a share, reported in the same quarter a year ago. Revenues rose 7.4% from $66.7 million to $62.1 million in the year-ago period.

Excluding the syndication charge, the company lost 12 cents a share for the period.

The two analysts surveyed by Thomson Financial predicted a loss of 17 cents a share.

Looking ahead, the company said it expects second-quarter revenue between $69 million and $72 million, with an operating loss of between $7.5 million and $9.5 million.

For the full year the company maintained its revenue guidance in the range of $330 million to $340 million, in line with expectations, and increased guidance for operating income by $4 million to a range of $9.5 million to $12.5 million.

The company also predicted second-quarter revenue of $69 million to $72 million and an adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) loss of $1 million to $3 million. That includes a $3 million investment in Blueprint magazine, the company said.

  Price   Change %Change
MSO
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Mad Money's Jim Cramer discusses Micron Technology and how the company gained control over inventory issues. The bears expect the company's history to repeat itself, but Cramer says this time, it feels different.

  • In this excerpt from a live CNBC interview, Warren Buffett explains why it's extremely unusual for a company's directors to vote against executive compensation plans.

  • Mad Money host Jim Cramer says shareholder activism works for every shareholder, and offers his take on the Valeant/Bill Ackman bid to acquire Allergan. The market is better off for these efforts, he says.